CN103908428A - Ponazuril nanosuspension and preparing method thereof - Google Patents

Ponazuril nanosuspension and preparing method thereof Download PDF

Info

Publication number
CN103908428A
CN103908428A CN201210594936.2A CN201210594936A CN103908428A CN 103908428 A CN103908428 A CN 103908428A CN 201210594936 A CN201210594936 A CN 201210594936A CN 103908428 A CN103908428 A CN 103908428A
Authority
CN
China
Prior art keywords
ponazuril
solution
nano suspension
recipe quantity
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210594936.2A
Other languages
Chinese (zh)
Inventor
刘桂兰
张新宇
夏雪林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Ringpu Bio Technology Co Ltd
Original Assignee
Tianjin Ringpu Bio Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Ringpu Bio Technology Co Ltd filed Critical Tianjin Ringpu Bio Technology Co Ltd
Priority to CN201210594936.2A priority Critical patent/CN103908428A/en
Publication of CN103908428A publication Critical patent/CN103908428A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the technical field of veterinary medicine, and relates to a preparing method of a ponazuril nanosuspension. The suspension can be administered through water drinking, and can be uniformly dispersed in water to form a stable solution system after being diluted. The nanosuspension has the characteristics of convenient administration, waste reduction and ensured dosage, and does not block a water fountain.

Description

Ponazuril nano suspension and preparation method thereof
Technical field
The invention belongs to field of veterinary, particularly a kind of ponazuril nano suspension and preparation method thereof.
Background technology
Chicken coccidiosis is the parasitic disease of being produced by the caused serious harm aviculture of Eimeria (Eimeria).The Eimeria parasitizing in Intestinum Gallus domesticus road has 7 kinds, is respectively Eimeria tenella (E.tenella), heap type Eimeria (E.acervulina), Eimeria Necatrix (E.necatrix), Eimeria maxima (E.maxima), Eimeria mitis (E.mitis), E.brunetti (E.brinetti) and precocious Eimeria (E.praecox).Various coccidiosiss are in the entozoic position of chicken digestive tract difference, Eimeria tenella parasitizes caecum, heap type Eimeria parasitizes duodenum, and Eimeria maxima and Eimeria Necatrix parasitize small intestinal, and E.brunetti parasitizes small intestinal hypomere and rectum.
Chicken coccidiosis Distribution Area is extensive, and the place of nearly all poultry has chicken coccidiosis to occur.According to the literature, the sickness rate of whole world chicken coccidiosis is up to 50%~70%.The economic loss that the whole world causes because of chicken coccidiosis every year exceedes 2,000,000,000 dollars.Poultry husbandry is one of the most general aquaculture in China, and especially south China, Southeastern China, Sw China, Central China, due to warmer climate humidity, is more conducive to existence and the propagation of coccidian oocyst, more serious to the harm of poultry husbandry.
The in the past multiple spring and autumn joint of being born in of this disease, along with the development of poultry husbandry, hatching changes long-term hatching into by seasonality, humiture becomes Artificial Control from natural regulating rotary, and along with the expansion of modern times cultivation scale, the increase of cultivation density, the space of also having created existence and having propagated to coccidian oocyst.This pathogen not only life cycle long, resistance is strong, general disinfecting drug is difficult to be killed, and suffers from chicken and still may have pathogen to discharge in several months after being ill, thereby pollutes cycle stretch-out.
Along with poultry environmental change, being widely used of coccidiosis medicine, and use coccidiostat lack of standardization, cause the drug resistance of coccidiosis to strengthen, and the infection scope of coccidiosis is also developed into into chicken and planted chicken by chickling gradually.Chicken coccidiosis infects into chicken, although majority is recessive symptom, can cause the growth promoter that is bred as chicken to be obstructed, and the rate of fertilization of survival rate, laying rate and hatching egg on kind of chicken etc. all can cause corresponding impact.
In recent years, modern poultry is already gradually to industrialization future development, intensive production in enormous quantities, intensive feeding manner and Artificial Control are suitable for the living environment of poultry husbandry development, although greatly promoted the production efficiency of poultry husbandry, but chicken group's high density, manually operated suitable humiture is also given the mutual propagation of chicken coccidiosis and is spread and created advantage.As can be seen here, chicken coccidiosis has become one of significant threat of current poultry husbandry.
Ponazuril is the main metabolites of toltrazuril, has another name called Ponazuril, has good protozoacide effect.Ponazuril (ponazuril) is the novel animal special-purpose medicaments of Triazinone of German Bayer AG late 1990s exploitation, for the ancillary drug of serious clinical response as alleviating the horse protozoacide encephalomyelitis (EPM) being caused by sarcocyst neuron; Its biological half-life is long, and bioavailability is high, and the EPM viruses such as horse are had to specially good effect.Its therapeutic effect is good, toxicity is low, is widely used for many years in states such as America and Europe, Asia.U.S. FDA has been ratified the ponazuril oral paste of the protozoacide encephalomyelitis that is used for the treatment of horse of Bayer AG and has been produced July calendar year 2001, content specification is 15%(w/w), adopted name is: Ponazuril Antiprotozoal Oral Paste is 141-188 in the relevant number of logging in of NADA.Simultaneously Bayer AG has obtained the patent (U.S.'s patent of invention, the patent No.: 5833095, in July, 1997 application time) of said preparation.
At present, the main purposes of ponazuril is the protozoacide encephalomyelitis that is used for the treatment of horse, and is the administering mode with oral paste.Domestic aspect, Hubei Long Xiang company has obtained the patent in the purposes of ponazuril crude drug in prevention and treatment coccidiosis, patent CN 102697787 A, on October 03rd, 2012 is open, disclose ponazuril expection and there is good anticoccidial effect, but because of its poorly water-soluble, be made generally in pre-mixing agent spice and use, for chicken medication, clinical use is extremely inconvenient.
Summary of the invention
The object of the present invention is to provide a kind of suspensoid that contains ponazuril and preparation method thereof, the administration of clinical practice drinking-water, easy to use.
Described ponazuril suspensoid, is take ponazuril as principal agent, and suitable pharmaceutic adjuvant in addition, the nano suspension of making after ultramicronising.
Described ponazuril suspensoid mainly comprises following composition:
Described surfactant is one or both in PEG-4000, Tween-80.
Described organic solvent is ethanol, N,N-dimethylacetamide combination, and both usage ratio are 9: 1.
Described ponazuril nano suspension is realized by following technical step:
(1) first sodium hydrogen citrate, anhydrous sodium sulfite are dissolved in a small amount of purified water, stirring and dissolving obtains solution A;
(2) get recipe quantity N,N-dimethylacetamide, add recipe quantity ponazuril to stir it is dissolved, obtain solution B;
(3) get purified water appropriate, add recipe quantity sodium carboxymethyl cellulose, heating for dissolving, after letting cool solution C;
(4) recipe quantity Tween-80, PEG-4000 are slowly added to mix homogeneously in solution B, then add wherein ethanol, add solution C after stirring and dissolving, solution D stirs to obtain;
(5) solution A is mixed with solution D, stir, be settled to recipe quantity by purified water;
(6) solution is passed through to high pressure homogenizer, pressure 700bar twice, obtains ponazuril nano suspension.
The invention has the beneficial effects as follows:
The nano suspension of the present invention administration of can drinking water, and can be dispersed in water after stock solution dilution, and keep stable suspended state, facilitate administration, cut the waste, guarantee dosage, do not stop up the advantages such as water fountain, simultaneously, said preparation has adhesion to the mucous membrane tissue in body, extend the medicine holdup time in vivo, improved the bioavailability of medicine, made this medicine can fully play drug effect in the time for the treatment of chicken coccidiosis.
The specific embodiment
Embodiment 1:
Prescription:
Compound method is
(1) first sodium hydrogen citrate, anhydrous sodium sulfite are dissolved in 200ml purified water, stirring and dissolving obtains solution A;
(2) get N,N-dimethylacetamide, ponazuril stirs it is dissolved, and obtains solution B;
(3) get purified water 2000ml, add recipe quantity sodium carboxymethyl cellulose, heating for dissolving, obtains solution C after letting cool;
(4) recipe quantity Tween-80 is slowly added to mix homogeneously in solution B, then add ethanol, add solution C after stirring and dissolving, solution D stirs to obtain;
(5) solution A is mixed with solution D, stir, be settled to 10000ml by purified water;
(6) solution is passed through to high pressure homogenizer, pressure 700bar twice, to obtain final product.
Embodiment 2:
Prescription:
 
Compound method is:
(1) first sodium hydrogen citrate, anhydrous sodium sulfite are dissolved in 500ml purified water, stirring and dissolving obtains solution A;
(2) get N,N-dimethylacetamide, add ponazuril to stir it is dissolved, obtain solution B;
(3) get purified water 3000ml, add recipe quantity sodium carboxymethyl cellulose, heating for dissolving, obtains solution C after letting cool;
(4) recipe quantity Tween-80, PEG-4000 are slowly added to mix homogeneously in solution B, then add wherein ethanol, add solution C after stirring and dissolving, solution D stirs to obtain;
(5) solution A is mixed with solution D, stir, be settled to recipe quantity by purified water;
(6) solution is passed through to high pressure homogenizer, pressure 700bar twice, obtains nanoscale ponazuril suspension.
Embodiment 3:
The prescription that contains ponazuril coccidium-resistant suspension:
 
Compound method is:
(1) first sodium hydrogen citrate, anhydrous sodium sulfite are dissolved in 500ml purified water, stirring and dissolving obtains solution A;
(2) get N,N-dimethylacetamide, add ponazuril to stir it is dissolved, obtain solution B;
(3) get purified water 3000ml, add recipe quantity sodium carboxymethyl cellulose, heating for dissolving, obtains solution C after letting cool;
(4) recipe quantity Tween-80, PEG-4000 are slowly added to mix homogeneously in solution B, then add wherein ethanol, add solution C after stirring and dissolving, solution D stirs to obtain;
(5) solution A is mixed with solution D, stir, be settled to recipe quantity by purified water;
(6) solution is passed through to high pressure homogenizer, pressure 700bar twice, obtains nanoscale ponazuril suspension.
Embodiment 4:
Clinical effect trial
1 material
Ponazuril pre-mixing agent (1%): for ponazuril and the anhydrous glucose equivalent dilution method that progressively increases formulated.
Ponazuril nano suspension prepared by the embodiment of the present invention one
2 methods
Select 20 age in days non-ball worms to infect chickling, be divided into four groups, be respectively mono-group of I group: embodiment, II group ponazuril pre-mixing agent group, III group positive controls infect not administration, IV group normal healthy controls group (not infecting not administration), every group of 20 chickens.Every chicken artificial challenge 5 × 10 4individual Eimeria Tenella egg capsule.Four groups respectively infect and on request medication within 7 days, all catch and kill afterwards, calculate each medicine anticoccidial index (ACI), judge anticoccidial effect.
3 experimental results
Table 1 ponazuril nano suspension, pre-mixing agent divide into groups to chicken coccidiosis clinical trial
Table 2 ponazuril nano suspension, the therapeutic effect of pre-mixing agent to chicken coccidiosis
Experiment conclusion: can find out from the experimental result of table 1: ponazuril nano suspension anticoccidial effect, higher than ponazuril pre-mixing agent, illustrates that preparation of the present invention can obviously improve clinical result of use and convenience.

Claims (5)

1. ponazuril nano suspension, is characterized in that this preparation is take ponazuril as principal agent, and suitable pharmaceutic adjuvant in addition, the nano suspension of making after ultramicronising.
2. ponazuril nano suspension according to claim 1, is characterized in that described ponazuril suspensoid comprises following composition:
3. ponazuril nano suspension according to claim 2, is characterized in that described surfactant is one or both in PEG-4000, Tween-80.
4. ponazuril nano suspension according to claim 3, is characterized in that described organic solvent is ethanol, N,N-dimethylacetamide combination, and both usage ratio are 9: 1.
5. ponazuril nano suspension according to claim 3, is characterized in that it realizes by following technical step:
(1) first sodium hydrogen citrate, anhydrous sodium sulfite are dissolved in a small amount of purified water, stirring and dissolving obtains solution A;
(2) get recipe quantity N,N-dimethylacetamide, add recipe quantity ponazuril to be stirred to dissolve, obtain solution B;
(3) get purified water appropriate, add recipe quantity sodium carboxymethyl cellulose, heating for dissolving, after letting cool solution C;
(4) recipe quantity Tween-80, PEG-4000 are slowly added to mix homogeneously in solution B, then add wherein ethanol, add solution C after stirring and dissolving, solution D stirs to obtain;
(5) solution A is mixed with solution D, stir, be settled to recipe quantity by purified water;
(6) solution is passed through to high pressure homogenizer, pressure 700bar twice, obtains ponazuril nano suspension.
CN201210594936.2A 2012-12-31 2012-12-31 Ponazuril nanosuspension and preparing method thereof Pending CN103908428A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210594936.2A CN103908428A (en) 2012-12-31 2012-12-31 Ponazuril nanosuspension and preparing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210594936.2A CN103908428A (en) 2012-12-31 2012-12-31 Ponazuril nanosuspension and preparing method thereof

Publications (1)

Publication Number Publication Date
CN103908428A true CN103908428A (en) 2014-07-09

Family

ID=51034635

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210594936.2A Pending CN103908428A (en) 2012-12-31 2012-12-31 Ponazuril nanosuspension and preparing method thereof

Country Status (1)

Country Link
CN (1) CN103908428A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113398094A (en) * 2021-05-11 2021-09-17 湖北龙翔药业科技股份有限公司 Insoluble veterinary drug nanosuspension and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113398094A (en) * 2021-05-11 2021-09-17 湖北龙翔药业科技股份有限公司 Insoluble veterinary drug nanosuspension and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1907264A (en) Compound sulfanilamide suspension and preparation method thereof
CN101810627B (en) Compound sulfamonomethoxine/compound sulfamonomethoxine sodium injection and preparation method
CN101496811B (en) Soluble and stable tilmicosin composition
CN104688683A (en) Albendazole suspension and preparation method thereof
CN101317904B (en) Uses of smoked plum extract in resisting virus, bacteria, mycoplasma or chlamydia of livestock and poultry
CN1943675A (en) Tibetan medicinal composition for expectorant, antitussive, antiasthmatic and its preparation method
JP6444515B2 (en) Application of taurine in the prevention and / or treatment of diseases caused by coronavirus and / or rotavirus viruses
CN105079819B (en) A kind of preparation method of anticoccidial Adprin hydroxypropyl beta cyclodextrin clathrate
CN103908428A (en) Ponazuril nanosuspension and preparing method thereof
CN110075068A (en) A kind of doxycycline hydrochloride soluble powder and preparation method thereof
CN103169652B (en) Veterinary alkaline lincomycin injection as well as preparation method and use thereof
CN103211818B (en) Pharmaceutical composition for treating or preventing bacterial and mycoplasma diseases of livestock and use thereof
CN101062066A (en) Compound isatis-root injection for animals and the preparing method thereof
CN102697725A (en) Veterinary ciprofloxacin lactate injection and preparation method thereof
CN103550226B (en) Compound sulfamonomethoxine sodium injection as well as preparation method thereof
CN102813909A (en) Compound doxycycline hydrochloride composition for preventing and treating colibacillosis and chronic respiratory disease of poultry as well as preparation method thereof
CN106668038A (en) Application of rhodosin in preparing anti-eimeria tenella drug
CN101879171A (en) Oral liquid preventing and curing gallinaceous leucocyto zoonosis and preparation method thereof
CN101904858A (en) Method for preparing coccidium-resistant suspension
CN101474165B (en) Polynucleotide microcapsule for treating diseases of livestock and poultry and preparation method thereof
CN102000100A (en) Anticoccidiosis nano suspension and preparation method thereof
CN108392469A (en) Application of the Tiopronin in preparing medicament for resisting Eimeria tenella
CN102973577B (en) Compound sodium sulfaquinoxaline composition for treating coccidiosis in young rabbits, and preparation method thereof
CN107669700A (en) A kind of medicine for treating ulcerative colitis and preparation method thereof
CN102688477A (en) Medicinal composition for treating respiratory diseases of livestock

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140709